February 5, 2026
The Alliance for Clinical Trials in Oncology is committed not only to finding new and better ways to treat cancer but also to identifying ways to help prevent cancer from occurring in the first place.
According to the National Cancer Institute, cancer prevention is any action taken to lower the chance of developing cancer. In addition to the physical challenges and emotional distress caused by cancer, the high cost of car
February 2, 2026 - A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to treat overactive bladder symptoms, reduces hot flashes compared to the placebo in men receiving hormone therapy for prostate cancer. This primary analysis of Alliance A222001 is published in the Journal of Clinical Oncology.
“Oxybutynin demonst
January 28, 2026
Addition of Palbociclib to Standard Maintenance Therapy Demonstrates Significant Progression-Free Survival Benefit in HR+, HER2+ Advanced Breast Cancer Alliance Foundation Trials, LLC (AFT) today announced the publication of the pivotal phase III PATINA study (AFT-38) in the New England Journal of Medicine (NEJM), marking a major milestone for patients with
